(2026). Blood‐based proteomic profiling reveals context‐dependent changes in BCL2‐associated signaling during taxane therapy in breast cancer patients. FEBS Open Bio.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Blood‐based Proteomic Profiling Reveals Context‐dependent Changes in BCL2‐associated Signaling During Taxane Therapy in Breast Cancer Patients."
FEBS Open Bio 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Blood‐based Proteomic Profiling Reveals Context‐dependent Changes in BCL2‐associated Signaling During Taxane Therapy in Breast Cancer Patients."
FEBS Open Bio, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.